Intrathecal treatment with liposomal cytarabine combined with systemic chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)

被引：0

作者：

Kowoll, A. ^{[1
]}

Pels, H. ^{[2
]}

Reiser, M. ^{[3
]}

Engert, A. ^{[3
]}

Herrlinger, U. ^{[4
]}

Lamprecht, M. ^{[5
]}

Egerer, G. ^{[6
]}

Vogt-Schaden, M. ^{[6
]}

Hau, P. ^{[7
]}

Schackert, G. ^{[8
]}

Reichmann, H. ^{[8
]}

Kroschinsky, F. ^{[8
]}

Schlegel, U. ^{[1
]}

Schmidt-Wolf, I ^{[4
]}

机构：

[1] Univ Klinikum Bochum, Bochum, Germany

[2] Krankenhaus Barmherzige Bruder, Regensburg, Germany

[3] Univ Klinikum Koln, Cologne, Germany

[4] Univ Klinkum Bonn, Bonn, Germany

[5] Christian Albrechts Univ Kiel Klinikum, Kiel, Germany

[6] Univ Klinikum Heidelberg, Heidelberg, Germany

[7] Univ Klinikum Regensburg, Regensburg, Germany

[8] Univ Klinikum Carl Gustav Carus, Dresden, Germany

来源：

ONKOLOGIE | 2010年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：47 / 47

页数：1

共 50 条

[21] Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study
Schlegel, U
Pels, H
Glasmacher, A
Kleinschmidt, R
Schmidt-Wolf, I
Helmstaedter, C
Fliessbach, K
Deckert, M
Van Roost, D
Fimmers, R
Bode, U
Klockgether, T
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (01): : 118 - 122
[22] Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma
Kim, Yu Ri
Cho, Hyunsoo
Kim, Soo-Jeong
Chung, Haerim
Kook, Hye Won
Jang, Ji Eun
Cheong, June-Won
Kim, Jin Seok
ONCOLOGIST, 2024, 29 (06): : e796 - e802
[23] Liposomal cytarabine in the treatment of primary or relapsed malignant lymphoma with central nervous system (CNS) involvement
Thorsgaard, M.
D'Amore, F.
ANNALS OF ONCOLOGY, 2008, 19 : 225 - 225
[24] Systemic Relapses In Primary CNS Lymphoma (PCNSL) - Unexpected Clonal Diversity
Fischer, Lars
Hummel, Michael
Korfel, Agnieszka
Lenze, Dido
Jahnke, Kristoph
Kiewe, Philipp
Weller, Michael
Thiel, Eckhard
BLOOD, 2010, 116 (21) : 1288 - 1288
[25] Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial
Roth, Patrick
Martus, Peter
Kiewe, Philipp
Moehle, Robert
Klasen, Hermann
Rauch, Michael
Roeth, Alexander
Kaun, Stephan
Thiel, Eckhard
Korfel, Agnieszka
Weller, Michael
NEUROLOGY, 2012, 79 (09) : 890 - 896
[26] Necessity of intraventricular chemotherapy with the modified Bonn protocol in primary CNS lymphoma (PCNSL) patients.
Schmidt-Wolf, Ingo G. H.
Pels, Hendrik
Juergens, Annika
Glasmacher, Axel
Schulz, Holger
Kroschinsky, Frank
Egerer, Gertlinde
Lamprecht, Monika
Wismeth, Caecilia
Schlegel, Uwe
BLOOD, 2006, 108 (11) : 694A - 695A
[27] SAFETY AND TOLERABILITY OF INTRATHECAL ADMINISTRSTION OF LIPOSOMAL CYTARABINE IN COMBINATION WITH DEXAMETHASONE AS CNS INVOLVEMENT PROPHYLAXIS AND TREATMENT IN LEUKEMIA/LYMPHOMA PATIENT
Piszcz, J.
Bolkun, L.
Szkiladz, M.
Lemancewicz, D.
Kloczko, J.
HAEMATOLOGICA, 2014, 99 : 547 - 547
[28] Safety and tolerability of intrathecal liposomal cytarabine during CNS prophylaxis in patients with non Hodgkin lymphoma and acute lymphoblastic leukemia
Annino, Luciana
Anaclerico, Barbara
Benevolo, Giulia
Cascavilla, Nicola
Cimminiello, Michele
Dell'Olio, Matteo
Gagliardi, Alfredo
Giordano, Giulio
Miraglia, Eustachio
Musso, Maurizio
Parvis, Guido
Piano, Silvia
Pilatrino, Chiara
Scalone, Renato
Venditti, Adriano
Venditti, Daniela
Vitolo, Umberto
Storti, Sergio
BLOOD, 2007, 110 (11) : 185B - 185B
[29] RETHINKING THE DOGMA: HOW IMPORTANT IS TREATMENT OF THE CSF IN PATIENTS WITH PRIMARY CNS LYMPHOMA (PCNSL)?
Aregawi, Dawit
Korfel, Agnieszka
Schlegel, Uwe
Glantz, Michael
NEURO-ONCOLOGY, 2019, 21 : 18 - 18
[30] Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
Fritsch, K.
Kasenda, B.
Hader, C.
Nikkhah, G.
Prinz, M.
Haug, V.
Haug, S.
Ihorst, G.
Finke, J.
Illerhaus, G.
ANNALS OF ONCOLOGY, 2011, 22 (09) : 2080 - 2085

← 1 2 3 4 5 →